Literature DB >> 33447685

Comprehensive treatment algorithm of postoperative spinal implant infection.

Justus Bürger1, Yannick Palmowski1, Matthias Pumberger1.   

Abstract

Postoperative spinal implant infection (PSII) is a commonly found and serious complication after instrumented spinal surgery. Whereas early-onset PSII usually can be diagnosed by clinical symptoms, the diagnosis of late-onset PSII can be often made only by examination of intraoperatively collected samples. The treatment of PSII consists of surgical and antibiotic therapy schemes. In case of early PSII, the retention of spinal implants is a feasible option, whereas late PSII is usually treated by one-staged exchange of the spinal implants. Radical debridement of surrounding tissue should be performed in any case of PSII. The antibiotic treatment depends on either the implants can be removed or need to be retained or exchanged, respectively. If the causative pathogens are sensitive for biofilm-active antibiotic agents, the duration of antibiotic treatment amounts to 12 weeks with retention of spinal implants. In case of problematic pathogens, the application of antibiotics needs to be prolonged for an individual duration. Antibiotic treatment should always be initiated with an intravenous application for at least 2 weeks. 2020 Journal of Spine Surgery. All rights reserved.

Entities:  

Keywords:  Revision spine surgery; infection, postoperative spinal implant infection (PSII); spine

Year:  2020        PMID: 33447685      PMCID: PMC7797808          DOI: 10.21037/jss-20-497

Source DB:  PubMed          Journal:  J Spine Surg        ISSN: 2414-4630


  2 in total

1.  Tissue sampling is non-inferior in comparison to sonication in orthopedic revision surgery.

Authors:  Theresa Fritsche; Matthias Schnetz; Alexander Klug; Sebastian Fischer; Christian Ruckes; K P Hunfeld; Reinhard Hoffmann; Yves Gramlich
Journal:  Arch Orthop Trauma Surg       Date:  2022-05-25       Impact factor: 3.067

2.  Incidence, risk factors and clinical course of pyogenic spondylodiscitis patients with pulmonary embolism.

Authors:  Daniel Dubinski; Sae-Yeon Won; Fee Keil; Bedjan Behmanesh; Max Dosch; Peter Baumgarten; Joshua D Bernstock; Volker Seifert; Thomas M Freiman; Florian Gessler
Journal:  Eur J Trauma Emerg Surg       Date:  2021-09-02       Impact factor: 2.374

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.